Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-OCS-13004722Phase 4Completed
Phase 4, open-label, single-arm trial of remifentanil in conditions requiring surgery, sponsored by Wenzhou Medical University. Primary endpoint: Pharmacokinetic parameters. Started Apr 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-OCS-13004722.